Walters William T 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 12:44 pm Purchase |
2025-01-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 7,050,000 9.900% |
550,000 (+8.46%) |
Filing |
| 2025-01-22 10:08 am Purchase |
2025-01-21 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 6,500,000 9.100% |
1,500,000 (+30.00%) |
Filing |
| 2025-01-08 6:49 pm Purchase |
2025-01-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 5,000,000 7.000% |
1,000,000 (+25.00%) |
Filing |
| 2024-12-10 12:42 pm Purchase |
2024-12-03 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 4,000,000 5.600% |
4,000,000 (New Position) |
Filing |